Week In Review: Moody Markets. 9 July 2021

Week In Review: Moody Markets

US equity indexes were up mildly on the week: DJIA +0.2%, S&P 500 +0.4%, NASDAQ +0.4 %. It was a back and forth week – Friday’s equity rally put US major indices in the green on the week after Thursday’s sell-off. The attention grabber this week was the fall in bond yields.  Given the moves in bond yields, the Exante Data Team took a closer look: 

“Global bond markets have staged a dramatic rally over the past few weeks, with the new tone from the Fed coinciding with a rethink of global growth risks, inflation dynamics as well as a substantial shift in positioning. But there has also been meaningful divergence between countries.

The chart below looks at rate moves since June 15 (the day before the FOMC statement) and up to Thursday’s close, and we would observe the following:

We have seen 10Y yields decline broadly in G10 (and in China) and in G10-like EMs (Poland, Korea). But EM trends are different.

Short-end moves (illustrated with 5-year rates) are different. We have seen increases in some G10 countries in which central banks are turning more hawkish (New Zealand and Canada stand out); and in EM space short rates have increased substantially in a long list of countries as hiking cycles are getting under way.

It is also worth noting that the largest decline in 5Y rates in our sample has been in China.”  Founder Jens Nordvig points out, “Since the Chinese yield curve is normally very low volatility (given more static monetary policy) this is highly unusual.”


Chart: The chart below looks at rate moves since June 15 (the day before the FOMC statement) and up to Thursday’s close.



Ahead Next Week: Select economic releases. Next week sees rate meetings by the RBNZ, BoC, Turkey, and BoJ, and a number of CPI releases. 
Monday, July 12:  India CPI (Jun), China Trade Balance (Jun), UK PM Johnson  expected to confirm a final decision on ending most restrictions in England, beginning July 19.
Tuesday, July 13:  BoE Financial Stability Report, Germany CPI (Jun), US CPI (Jun), Turkey monetary policy decision, RBNZ monetary policy decision. 
Wednesday, July 14:  UK CPI (Jun), Sweden CPI (Jun), Fed Chair Powell testimony – Semiannual Monetary Policy Report to the Congress (House), Bank of Canada monetary policy decision and monetary policy report, Speech ECB’s Schnabel at PIIE:  “Challenges of the low interest rate era”, Korea trade balance (Jun), Australia employment (Jun), China GDP (Q2).
Thursday, July 15:  India Trade Balance (Jun), Fed Chair Powell testimony – Semiannual Monetary Policy Report to the Congress (Senate Banking Committee), US initial claims, NZ CPI (Q2), BoJ monetary policy decision.
Friday, July 16:  EZ CPI (Jun), EZ trade balance (May), US retail sales (Jun), US U of Michigan Sentiment/inflation expectations (Jul), US TIC data (May). 

USD Comment

USD strengthened since last Friday – see here. The DXY Index ranged 92.01 – 92.82, finishing the week at 92.10.  EURUSD ranged 1.1893-1.1784. JPY gained vs USD on the week. USDJPY low was 109.54, which came on Thursday – the US equity sell-off day, so it was a classic safe haven gain. Looking at a wider group of pairs, USD outperformance is more pronounced, as risk aversion pushed EMFX lower. Importantly, in the 10Y tenor, US rate differentials do seem to strengthen broadly, supporting USD’s moves this week (chart below).

Chart: USD returns vs 10Y interest rate differentials



Covid-19 Update

In thinking about the Delta variant, it is important to examine the UK data as the delta variant has been circulating for longer there, allowing its effects to show up in the data both in terms of cases, hospitalizations and deaths. In the UK, cases are increasingly concentrated among the young, unvaccinated population. Meanwhile, fatality and hospitalization rates for people less than 20 years old are very close to flu levels at 0.01% and 0.4%, respectively.  The combination of a higher prevalence among the young, and steady to declining severity among older groups, has lead to a continued decrease in national level hospitalization and fatality rates. The national fatality rate now stands at 0.28% (chart below).  Case fatality rate (CFR) has dropped sharply since the spike in January, and at <0.3% is now approaching what you typically find for seasonal flu.

This week, the UK adopted, in PM Johnson’s words, a “learn to live with” the virus strategy saying that at his government plans to drop laws requiring face masks and social distancing later this month. The final stage of re-opening, which had been pushed back, is scheduled to take place on July 19th. 
Chart: UK Coronavirus Cases and Case Fatality Rate


Turning to the US, early evidence points to lower CFRs; but we do not yet have a big delta spike on hand – see this chart. Case momentum seems to be worsening in a handful of states including Arizona and Missouri, but we have seen a similar pattern of falling fatality ratios. See here for counties more vaccinated and less vaccinated. In the current problem states and other big states, fatality ratios appear to be less than half as large as this time in 2020 and are hovering at 1.5% across a broad swath of the population (chart below). 


Chart: Comparing Summer Waves in the US: Fatality Rates (%) June avg.



Exante Data Happenings & Media

Turning to central banks, Senior Advisor Chris Marsh gave his opinion on the ECB’s strategy review in this Twitter thread. 


We have introduced new charts on Twitter updated daily including:

G10 bond yields – 24 hour change

Daily returns of major cryptocurrencies and other global assets

Momentum of ETF flows by sector

 Top 10 weekly ETF flows.


Bloomberg users – you can view Exante Data tweets on the terminal. Users can type into the blue command line: TWEETS BY EXANTE <GO>. Alternatively, to add to Launchpad:  1. Run SOCI <GO> 2. Type into the orange box Exante 3. Select the handle at the bottom “TWT_EXANTEDATA” 4. Click the white LLP <GO> to Open in Launchpad to view in Launchpad mode 5. To save the search >>> Click Actions in the top red tool bar >> Save Search


How to reach us: 

  • Our Substack is public  – Join us in discussing and debating macroeconomic topics – Subscribe here
  • If you are an institution and would like more information on our Macro Strategy, Global Flow Analytics, Exante Data API services, Digital Currency Series, and/or our Covid-19 vaccine rollout tracking and Tourism Recovery tracking — please reach out to us here.

Exante Data © 2021. All rights reserved. Personal Data Usage Policy

This site is provided for informational purposes only.  The information included in this site should not be used as the sole basis for making a decision as to whether or not to invest in any particular security. In making an investment decision, you must rely on your own examination of the securities and the terms of the offering. You should not construe the contents of these materials as legal, tax, investment or other advice, or a recommendation to purchase or sell any particular security.

The information included in this site is based upon information reasonably available to Exante as of the date noted herein. Furthermore, the information included in this site has been obtained from sources that Exante believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness. Information contained in this site does not purport to be complete, nor does Exante undertake any duty to update the information set forth herein. No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained herein, by Exante, its members, partners or employees, and no liability is accepted by such persons for the accuracy or completeness of any such information.

This site contains certain “forward-looking statements,” which may be identified by the use of such words as “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” “potential,” “outlook,” “forecast,” “plan” and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of certain investment strategy. All are subject to various factors, including, but not limited to, general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting the operations of the companies identified herein, any or all of which could cause actual results to differ materially from projected results.

Get more information about Exante Data
Get Ahead With Our Updates with Our Exante Newsletter